串扰
结直肠癌
医学
免疫抑制
炎症
巨噬细胞极化
重编程
癌症研究
表型
免疫学
肿瘤进展
代谢活性
肿瘤微环境
生物信息学
结肠炎
代谢途径
通路分析
治疗方法
癌症
大肠癌小鼠模型的建立
肿瘤科
巨噬细胞
内科学
作者
Long Xie,Xing Wei,Ren Zelian,Can Cen,Yihan Hu,Xiang Li,Qiang Sun
标识
DOI:10.1016/j.phrs.2026.109663
摘要
Colorectal cancer (CRC) remains a leading cause of cancer mortality. Tumor-associated macrophages (TAMs) regulate CRC progression through functional polarization and metabolic reprogramming. Beyond the classical M1/M2 paradigm, single-cell and spatial studies reveal heterogeneous TAM subsets with distinct metabolic programs, spatial organization, and stage-dependent functions. This review delineates how TAM metabolic reprogramming drives CRC via metabolite-induced PD-L1 expression, oncogenic signaling, and crosstalk with chronic inflammation and gut microbiota. We emphasize spatial metabolic heterogeneity, TAM-tumor metabolic symbiosis, the stage-dependent duality of M2-like macrophages in colitis versus CRC, and pathogen-driven cross-kingdom manipulation. Clinical evidence linking TAM metabolic features to molecular subtypes, metastasis, prognosis, and treatment response is integrated, and methodological challenges in distinguishing true metabolic reprogramming from phenotypic changes are discussed. Therapeutic strategies targeting TAM metabolism, including small molecules, chemotherapeutics, TCM, nanomedicine, probiotics, and combinations, are summarized, offering precise TAM reprogramming to reverse immunosuppression and overcome CRC therapeutic bottlenecks.
科研通智能强力驱动
Strongly Powered by AbleSci AI